Valeant CEO On Allegations Against The Company And Future M&A Deals By: Benzinga via Benzinga January 14, 2015 at 08:38 AM EST Even though its bid for Allergan, Inc. (NYSE: AGN) was not successful, Valeant Pharmaceuticals Intl Inc (NYSE: VRX) has tasted ... Read More >> Related Stocks: Valeant Pharmaceuticals International, Inc.